Get access

Nitazoxanide for chronic hepatitis C virus infection

  • Protocol
  • Intervention

Authors

  • Kristiana Nikolova,

    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    Search for more papers by this author
  • Shahira Ahmed Afifi,

    1. Faculty of Medicine, Cairo University, Endemic Medicine Department, Cairo, Egypt
    Search for more papers by this author
  • Naglaa Zayed,

    1. Faculty of Medicine, Cairo University, Endemic Medicine Department, Cairo, Egypt
    Search for more papers by this author
  • Tahany Awad,

    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    Search for more papers by this author
  • Shereen Hunter,

    1. Faculty of Medicine, Cairo University, Endemic Medicine Department, Cairo, Egypt
    Search for more papers by this author
  • Ayman Amer,

    1. Faculty of Medicine, Cairo University, Endemic Medicine Department, Cairo, Egypt
    Search for more papers by this author
  • Christian Gluud,

    Corresponding author
    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    • Christian Gluud, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. cgluud@ctu.rh.dk.

    Search for more papers by this author
  • Mahasen Mabrouk

    1. Faculty of Medicine, Cairo University, Endemic Medicine and Liver Department, Cairo, Egypt
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To systematically evaluate the benefits and harms of nitazoxanide for treatment of chronic hepatitis C patients.

Get access to the full text of this article

Ancillary